Clinical trial
A Study To Evaluate The Efficacy And Safety Of Betahistine Mesilate In The…
NCT00474409 · Eisai Inc., Industry · Withdrawn
Key facts
| NCT number | NCT00474409 |
|---|---|
| Title | A Study To Evaluate The Efficacy And Safety Of Betahistine Mesilate In The Treatment Of Patients With Vertigo Caused By Cerebral Infarction In Posterior Circulation |
| Official title | A Multicenter, Placebo-Controlled, Double-Blind Study To Evaluate The Efficacy And Safety Of Betahistine Mesilate In The Treatment Of Patients With Vertigo Caused By Cerebral Infarction In Posterior Circulation |
| Lead sponsor | Eisai Inc., Industry |
| Status | Withdrawn |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Vertigo |
| Intervention type | Drug |
| Interventions | Merislon |
| Enrollment | 0 |
| Start date | May 1, 2007 |
| First posted | May 16, 2007 |
| Last update posted | Jun 5, 2017 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: